Keith Tan
AstraZeneca (United Kingdom)(GB)University of Cambridge(GB)Cambridge University Hospitals NHS Foundation Trust(GB)Cancer Research UK Cambridge Center(GB)AstraZeneca (Switzerland)(CH)AstraZeneca (Spain)(ES)
Publications by Year
Research Areas
Pain Mechanisms and Treatments, Renal Transplantation Outcomes and Treatments, Antibiotics Pharmacokinetics and Efficacy, Antifungal resistance and susceptibility, Transplantation: Methods and Outcomes
Most-Cited Works
- → Adaptive Rejection Metropolis Sampling within Gibbs Sampling(1995)684 cited
- → Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity(2012)359 cited
- → Investigation of the Potential Relationships Between Plasma Voriconazole Concentrations and Visual Adverse Events or Liver Function Test Abnormalities(2006)254 cited
- → VCP/p97 regulates Beclin-1-dependent autophagy initiation(2021)140 cited
- → Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo(2019)111 cited
- → Effect of omeprazole on the steady‐state pharmacokinetics of voriconazole(2003)105 cited